Chosa Oncology AB (FRA:W5L) Cyclically Adjusted FCF per Share: €-0.15 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:W5L Chosa Oncology AB FRA:W5L
31 GF Score
Price €0.06
View Full Analysis

What is Chosa Oncology AB Cyclically Adjusted FCF per Share?

Chosa Oncology AB FRA:W5L -10.42% 31 Cyclically Adjusted FCF per Share is €-0.15 as of Mar. 2026. GuruFocus rates FRA:W5L with a GF Score™ of 31/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chosa Oncology AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.15 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-23), Chosa Oncology AB's current stock price is €0.0602. Chosa Oncology AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.15. Chosa Oncology AB's Cyclically Adjusted Price-to-FCF of today is .


Chosa Oncology AB  (FRA:W5L) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chosa Oncology AB Cyclically Adjusted FCF per Share Related Terms


Chosa Oncology AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB Cyclically Adjusted FCF per Share Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.18

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.17 -0.14 -0.18 -0.15

FRA:W5L vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Chosa Oncology AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chosa Oncology AB Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chosa Oncology AB's Cyclically Adjusted Price-to-FCF falls into.


FRA:W5L
31GF Score
Chosa Oncology AB FRA:W5L
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chosa Oncology AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chosa Oncology AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.003/133.5600*133.5600
=-0.003

Current CPI (Mar. 2026) = 133.5600.

Chosa Oncology AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.040 101.019 -0.053
201609 -0.017 101.138 -0.022
201612 -0.071 102.022 -0.093
201703 -0.036 102.022 -0.047
201706 -0.042 102.752 -0.055
201709 -0.031 103.279 -0.040
201712 -0.038 103.793 -0.049
201803 -0.036 103.962 -0.046
201806 -0.034 104.875 -0.043
201809 -0.053 105.679 -0.067
201812 -0.034 105.912 -0.043
201903 -0.052 105.886 -0.066
201906 -1.004 106.742 -1.256
201909 0.360 107.214 0.448
201912 0.005 107.766 0.006
202003 -0.048 106.563 -0.060
202006 -0.046 107.498 -0.057
202009 -0.062 107.635 -0.077
202012 -0.083 108.296 -0.102
202103 -0.010 108.360 -0.012
202106 -0.090 108.928 -0.110
202109 -0.084 110.338 -0.102
202112 -0.053 112.486 -0.063
202203 -0.077 114.825 -0.090
202206 -0.068 118.384 -0.077
202209 -0.021 122.296 -0.023
202212 0.156 126.365 0.165
202303 -0.005 127.042 -0.005
202306 -0.019 129.407 -0.020
202309 -0.002 130.224 -0.002
202312 0.008 131.912 0.008
202403 -0.001 132.205 -0.001
202406 -0.003 132.716 -0.003
202409 -0.002 132.304 -0.002
202412 0.001 132.987 0.001
202503 -0.004 132.825 -0.004
202506 -0.002 133.699 -0.002
202509 -0.004 133.480 -0.004
202512 0.004 133.390 0.004
202603 -0.003 133.560 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.15 mean?
Chosa Oncology AB (FRA:W5L) has a Cyclically Adjusted FCF per Share of €-0.15 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Chosa Oncology AB and its competitors.
Is Chosa Oncology AB's Cyclically Adjusted FCF per Share too high?
Chosa Oncology AB's current Cyclically Adjusted FCF per Share is €-0.15. Overall, Chosa Oncology AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Chosa Oncology AB's Cyclically Adjusted FCF per Share of €-0.15 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Chosa Oncology AB and its competitors. Chosa Oncology AB's current Cyclically Adjusted FCF per Share is €-0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (FRA:W5L) has a current Cyclically Adjusted FCF per Share of €-0.15. The current Cyclically Adjusted FCF per Share is €-0.15. Chosa Oncology AB's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Chosa Oncology AB (FRA:W5L), the current Cyclically Adjusted FCF per Share is €-0.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Other Exchanges CHOSA:Sweden
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
31GF Score

Get the complete analysis for FRA:W5L

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price